You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

16-024

Showing 1 - 25 of 6,388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Deficiency Disorder Trial in Worldwide (octanorm 16.5%)

Completed
Has Results
  • Primary Immune Deficiency Disorder
  • octanorm 16.5%
  • Birmingham, Alabama
  • +23 more
Jul 26, 2021

SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza

Active, not recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • SARS-CoV-2 rS/Matrix M1-Adjuvant
  • +2 more
  • Belfast, Antrim, United Kingdom
  • +32 more
Oct 19, 2022

Papillomavirus Infections Trial in Quzhou, Shaoxing (V503)

Active, not recruiting
  • Papillomavirus Infections
  • V503
  • Quzhou, Zhejiang, China
  • +1 more
Aug 17, 2022

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

Kidney Diseases, Diabetic Nephropathies, Diabetes Complications Trial in San Antonio (GFB-024, Placebo)

Completed
  • Kidney Diseases
  • +4 more
  • San Antonio, Texas
    Worldwide Clinical Trials
Mar 24, 2022

Prurigo Nodularis Trial in Worldwide (INCB054707, Placebo)

Recruiting
  • Prurigo Nodularis
  • Phoenix, Arizona
  • +48 more
Dec 1, 2022

Identify Barriers to Allogeneic Hematopoietic Stem Cell

Recruiting
  • Acute Leukemia
  • +2 more
  • assessments
  • Hartford, Connecticut
  • +2 more
Jan 21, 2022

Stress Urinary Incontinence Trial in Royal Oak, Bala-Cynwyd, Philadelphia (GTx-024)

Completed
Has Results
  • Stress Urinary Incontinence
  • Royal Oak, Michigan
  • +2 more
Jan 12, 2021

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Advanced Solid Tumor Trial in China (LBL-024 for Injection)

Recruiting
  • Advanced Solid Tumor
  • LBL-024 for Injection
  • Beijing, Beijing, China
  • +7 more
Apr 26, 2022

Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT

Recruiting
  • Lung Cancer Stage III
  • Lung Cancer Stage IV
    • Brest, France
      Chu Brest
    Aug 16, 2023

    Triple Negative Breast Cancer Trial in United States (GTx-024)

    Terminated
    Has Results
    • Triple Negative Breast Cancer
    • Fort Lauderdale, Florida
    • +6 more
    Oct 29, 2020

    Metastatic Colorectal Cancer Trial in Worldwide (Cetuximab, Panitumumab)

    Completed
    Has Results
    • Metastatic Colorectal Cancer
    • Stockton, California
    • +151 more
    Sep 8, 2022

    Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)

    Recruiting
    • Ocular Hypertension
    • Latanoprostene Bunod
    • Placebo
    • Rochester, Minnesota
      Bausch Site 001
    Sep 29, 2022

    ER+ and AR+ Breast Cancer Trial in United States (GTx-024)

    Completed
    Has Results
    • ER+ and AR+ Breast Cancer
    • Fort Lauderdale, Florida
    • +3 more
    Dec 8, 2020

    Muscle Wasting, NSCLC Trial in United States (GTx-024, )

    Completed
    Has Results
    • Muscle Wasting
    • Non-Small Cell Lung Cancer
    • Birmingham, Alabama
    • +29 more
    Oct 26, 2020

    COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

    Completed
    • COVID-19
    • BRII-196
    • +3 more
    • Tucson, Arizona
    • +106 more
    Mar 24, 2023

    COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

    Completed
    • COVID-19
    • VIR-7831
    • +2 more
    • Tucson, Arizona
    • +104 more
    Mar 22, 2023

    ADHD, Dyslexia Trial in New Haven (Atomoxetine, Placebo)

    Completed
    Has Results
    • Attention Deficit Hyperactivity Disorder
    • Dyslexia
    • New Haven, Connecticut
      Yale University School of Medicine
    Oct 9, 2022

    Parkinson Disease Trial in Nijmegen (Cueing app)

    Recruiting
    • Parkinson Disease
    • Cueing app
    • Nijmegen, Netherlands
      Radboudumc
    Nov 16, 2023

    HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

    Active, not recruiting
    Has Results
    • HIV-1 Infection
    • Doravirine, Tenofovir, Lamivudine
    • +4 more
    • (no location specified)
    Sep 2, 2022

    Type 1 Diabetes Trial in Puerto Rico, United States (HOE901-U300 (Insulin Glargine 300 U/ml), Lantus (Insulin Glargine 100

    Completed
    Has Results
    • Type 1 Diabetes Mellitus
    • HOE901-U300 (Insulin Glargine 300 U/ml)
    • +2 more
    • Little Rock, Arkansas
    • +99 more
    Mar 21, 2022

    Prurigo Nodularis Trial in Worldwide (Nemolizumab 30 mg, Placebo)

    Recruiting
    • Prurigo Nodularis
    • Nemolizumab 30 mg
    • Placebo
    • Birmingham, Alabama
    • +109 more
    Jun 29, 2022

    Time Restricted Feeding, Myocardial Infarction, Atherosclerotic Cardiovascular Disease Trial in Nijmegen (Time restricted eating

    Recruiting
    • Time Restricted Feeding
    • +2 more
    • Time restricted eating (TRE)
    • Regular diet
    • Nijmegen, Gelderland, Netherlands
      Radboud university medical center
    Dec 5, 2022